Setting

North America Oncology Informatics Market 2020-2030 by Product Type (EHR, PHM, CDSS, DDDI), Cancer Type, Application (Medical, Surgical, Radiation), End User, and Country: Trend Forecast and Growth Opportunity

Published: 26 Aug 2020 | Report Code: 10247666 | Pages: 109

North America oncology informatics market is expected to grow by 5.7% annually in the forecast period and reach $3,483.9 million by 2030 driven by the surge of cancer incidence, increasing cost of cancer treatment, and growing trend of reducing medical errors and readmission rates. Highlighted with 28 tables and 43 figures, this 109-page report “North America Oncology Informatics Market 2020-2030 by Product Type (EHR, PHM, CDSS, DDDI), Cancer Type, Application (Medical, Surgical, Radiation), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America oncology informatics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America oncology informatics market in every aspect of the classification from perspectives of Product Type, Cancer Type, Application, End User, and Country. Based on Product Type, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Electronic Health Records (EHRs) • Population Health Management (PHM) • Clinical Decision Support System (CDSS) • Drug Discovery and Development Informatics (DDDI) • Data Analytics • Image Analytics • Other Product Types Based on Cancer Type, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Colorectal Cancer • Breast Cancer • Prostate Cancer • Cervical Cancer • Other Cancers Based on Application, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Medical Application • Surgical Application • Radiation Application Based on End User, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Pharmaceutical Companies • Life Science Companies • Contract Research Organizations (CROs) • Academic Institutes and Research Centers • Other End Users Geographically, the following national/local markets are fully investigated: • U.S. • Canada • Mexico For each country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of key national markets by Product Type, Cancer Type, and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Specifically, potential risks associated with investing in North America oncology informatics market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions. Key Players (this may not be a complete list and extra companies can be added upon request): Cerner Corporation Change Healthcare Elekta AB F.Hoffmann-La Roche Ltd. Hologic Inc. IBM Corporation Inspirata Inc. Koninklijke Philips N.V. Laboratory Corporation of America Holdings McKesson Corporation MIM Software, Inc. Oncology Analytics, Inc PerkinElmer, Inc. RELX Group Sirenas, LLC UnitedHealth Group, Inc Varian Medical Systems, Inc (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) 

Table Of Contents

1 Introduction	7
1.1 Industry Definition and Research Scope	7
1.1.1 Industry Definition	7
1.1.2 Research Scope	8
1.2 Research Methodology	11
1.2.1 Overview of Market Research Methodology	11
1.2.2 Market Assumption	12
1.2.3 Secondary Data	12
1.2.4 Primary Data	12
1.2.5 Data Filtration and Model Design	14
1.2.6 Market Size/Share Estimation	15
1.2.7 Research Limitations	16
1.3 Executive Summary	17
2 Market Overview and Dynamics	20
2.1 Market Size and Forecast	20
2.1.1 Impact of COVID-19 on the Market	21
2.2 Major Growth Drivers	23
2.3 Market Restraints and Challenges	26
2.4 Emerging Opportunities and Market Trends	29
2.5 Porter’s Fiver Forces Analysis	33
3 Segmentation of North America Market by Product Type	37
3.1 Market Overview by Product Type	37
3.2 Electronic Health Records (EHRs)	39
3.3 Population Health Management (PHM)	41
3.4 Clinical Decision Support System (CDSS)	43
3.5 Drug Discovery and Development Informatics (DDDI)	45
3.6 Data Analytics	47
3.7 Image Analytics	48
3.8 Other Product Types	49
4 Segmentation of North America Market by Cancer Type	50
4.1 Market Overview by Cancer Type	50
4.2 Colorectal Cancer	52
4.3 Breast Cancer	53
4.4 Prostate Cancer	54
4.5 Cervical Cancer	55
5 Segmentation of North America Market by Application	56
5.1 Market Overview by Application	56
5.2 Medical Application	58
5.3 Surgical Application	59
5.4 Radiation Application	60
6 Segmentation of North America Market by End User	62
6.1 Market Overview by End User	62
6.2 Pharmaceutical Companies	64
6.3 Life Science Companies	65
6.4 Contract Research Organizations (CROs)	66
6.5 Academic Institutes and Research Centers	67
6.6 Other End Users	68
7 North America Market 2019-2030 by Country	69
7.1 Overview of North America Market	69
7.2 U.S.	72
7.3 Canada	76
7.4 Mexico	78
8 Competitive Landscape	80
8.1 Overview of Key Vendors	80
8.2 New Product Launch, Partnership, Investment, and M&A	84
8.3 Company Profiles	85
Cerner Corporation	85
Change Healthcare	87
Elekta AB	88
F.Hoffmann-La Roche Ltd.	89
Hologic Inc.	90
IBM Corporation	91
Inspirata Inc.	92
Koninklijke Philips N.V.	93
Laboratory Corporation of America Holdings	94
McKesson Corporation	95
MIM Software, Inc.	96
Oncology Analytics, Inc	97
PerkinElmer, Inc.	98
RELX Group	99
Sirenas, LLC	100
UnitedHealth Group, Inc	101
Varian Medical Systems, Inc	102
9 Investing in North America Market: Risk Assessment and Management	103
9.1 Risk Evaluation of North America Market	103
9.2 Critical Success Factors (CSFs)	106
Related Reports and Products	109
List Of Tables

Table 1.  Snapshot of North America Oncology Informatics Market, 2019-2030	18
Table 2.  Main Product Trends and Market Opportunities in North America Oncology Informatics Market	29
Table 3. North America Oncology Informatics Market by Product Type, 2019-2030, $ mn	37
Table 4. Key Products and EHR Vendors	40
Table 5. Key Products and PHM Vendors	42
Table 6. Key Products and CDSS Vendors	44
Table 7. Key Products and DDDI Vendors	46
Table 8. North America Oncology Informatics Market by Cancer Type, 2019-2030, $ mn	50
Table 9. North America Oncology Informatics Market by Application, 2019-2030, $ mn	56
Table 10. North America Oncology Informatics Market by End User, 2019-2030, $ mn	62
Table 11. North America Oncology Informatics Market by Country, 2019-2030, $ mn	70
Table 12. U.S. Oncology Informatics Market by Product Type, 2019-2030, $ mn	74
Table 13. U.S. Oncology Informatics Market by Cancer Type, 2019-2030, $ mn	74
Table 14. U.S. Oncology Informatics Market by End User, 2019-2030, $ mn	74
Table 15. Canada Oncology Informatics Market by Product Type, 2019-2030, $ mn	77
Table 16. Canada Oncology Informatics Market by Cancer Type, 2019-2030, $ mn	77
Table 17. Canada Oncology Informatics Market by End User, 2019-2030, $ mn	77
Table 18. Mexico Oncology Informatics Market by Product Type, 2019-2030, $ mn	79
Table 19. Mexico Oncology Informatics Market by Cancer Type, 2019-2030, $ mn	79
Table 20. Mexico Oncology Informatics Market by End User, 2019-2030, $ mn	79
Table 21. Breakdown of North America Market by Key Vendor, 2019, %	82
Table 22. Cerner Corporation: Company Snapshot	85
Table 23. Cerner Corporation: Business Segmentation	85
Table 24. Cerner Corporation: Product Portfolio	86
Table 25. Cerner Corporation: Revenue, 2016-2018, $ mn	86
Table 26. Cerner Corporation: Recent Developments	86
Table 27.  Risk Evaluation for Investing in North America Market, 2019-2030	104
Table 28. Critical Success Factors and Key Takeaways	107
List Of Figures

Figure 1. Research Method Flow Chart	11
Figure 2. Breakdown of Primary Research	13
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation	15
Figure 4. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030	17
Figure 5. North America Oncology Informatics Market, 2019-2030, $ mn	20
Figure 6. Impact of COVID-19 on Business	21
Figure 7. Primary Drivers and Impact Factors of North America Oncology Informatics Market	23
Figure 8. Primary Restraints and Impact Factors of North America Oncology Informatics Market	26
Figure 9. Investment Opportunity Analysis	30
Figure 10. Porter’s Fiver Forces Analysis of North America Oncology Informatics Market	33
Figure 11. Breakdown of North America Oncology Informatics Market by Product Type, 2019-2030, % of Revenue	38
Figure 12. North America Addressable Market Cap in 2020-2030 by Product Type, Value ($ mn) and Share (%)	38
Figure 13. North America Oncology Informatics Market: Electronic Health Records (EHRs), 2019-2030, $ mn	39
Figure 14. North America Oncology Informatics Market: Population Health Management (PHM), 2019-2030, $ mn	41
Figure 15. North America Oncology Informatics Market: Clinical Decision Support System (CDSS), 2019-2030, $ mn	43
Figure 16. North America Oncology Informatics Market: Drug Discovery and Development Informatics (DDDI), 2019-2030, $ mn	45
Figure 17. North America Oncology Informatics Market: Data Analytics, 2019-2030, $ mn	47
Figure 18. North America Oncology Informatics Market: Image Analytics, 2019-2030, $ mn	48
Figure 19. North America Oncology Informatics Market: Other Product Types, 2019-2030, $ mn	49
Figure 20. Breakdown of North America Oncology Informatics Market by Cancer Type, 2019-2030, % of Sales Revenue	50
Figure 21. North America Addressable Market Cap in 2020-2030 by Cancer Type, Value ($ mn) and Share (%)	51
Figure 22. North America Oncology Informatics Market: Colorectal Cancer, 2019-2030, $ mn	52
Figure 23. North America Oncology Informatics Market: Breast Cancer, 2019-2030, $ mn	53
Figure 24. North America Oncology Informatics Market: Prostate Cancer, 2019-2030, $ mn	54
Figure 25. North America Oncology Informatics Market: Cervical Cancer, 2019-2030, $ mn	55
Figure 26. Breakdown of North America Oncology Informatics Market by Application, 2019-2030, % of Sales Revenue	56
Figure 27. North America Addressable Market Cap in 2020-2030 by Application, Value ($ mn) and Share (%)	57
Figure 28. North America Oncology Informatics Market: Medical Application, 2019-2030, $ mn	58
Figure 29. North America Oncology Informatics Market: Surgical Application, 2019-2030, $ mn	59
Figure 30. North America Oncology Informatics Market: Radiation Application, 2019-2030, $ mn	60
Figure 31. Breakdown of North America Oncology Informatics Market by End User, 2019-2030, % of Revenue	62
Figure 32. North America Addressable Market Cap in 2020-2030 by End User, Value ($ mn) and Share (%)	63
Figure 33. North America Oncology Informatics Market: Pharmaceutical Companies, 2019-2030, $ mn	64
Figure 34. North America Oncology Informatics Market: Life Science Companies, 2019-2030, $ mn	65
Figure 35. North America Oncology Informatics Market: Contract Research Organizations (CROs), 2019-2030, $ mn	66
Figure 36. North America Oncology Informatics Market: Academic Institutes and Research Centers, 2019-2030, $ mn	67
Figure 37. North America Oncology Informatics Market: Other End Users, 2019-2030, $ mn	68
Figure 38. Breakdown of North America Oncology Informatics Market by Country, 2019 and 2030, % of Revenue	70
Figure 39. Contribution to North America 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)	71
Figure 40. U.S. Oncology Informatics Market, 2019-2030, $ mn	73
Figure 41. Canada Oncology Informatics Market, 2019-2030, $ mn	76
Figure 42.  Oncology Informatics Market in Mexico, 2015-2030, $ mn	78
Figure 43. Growth Stage of North America Oncology Informatics Industry over the Forecast Period	80


Key Players (this may not be a complete list and extra companies can be added upon request): 
Cerner Corporation	
Change Healthcare	
Elekta AB	
F.Hoffmann-La Roche Ltd.	
Hologic Inc.	
IBM Corporation	
Inspirata Inc.	
Koninklijke Philips N.V.	
Laboratory Corporation of America Holdings	
McKesson Corporation	
MIM Software, Inc.	
Oncology Analytics, Inc	
PerkinElmer, Inc.	
RELX Group	
Sirenas, LLC	
UnitedHealth Group, Inc	
Varian Medical Systems, Inc